Nivolumab trials for Stage III Lung Cancer AJCC v8

All Nivolumab trials · All Stage III Lung Cancer AJCC v8 trials

Phase breakdown

Recruiting trials studying Nivolumab for Stage III Lung Cancer AJCC v8

• Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
  NCT06495125 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
  NCT06731270 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
  NCT05098210 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Nivolumab for Stage III Lung Cancer AJCC v8?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.